ATI-2173

Antios, months after series B, raises a further $75M to fuel pursuit of hepatitis B cure
Fierce Biotech
Wed, 11/3/21 - 10:46 am
Antios
hepatitis B
ATI-2173
funding
Race for hepatitis B drug intensifies as Antios raises $96m for phase 2 trial
Pharmaforum
Tue, 04/13/21 - 10:18 am
Antios
funding
hepatitis B
ATI-2173